首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

2144800

2026-2030年全球快速微生物檢測市場

Global Rapid Microbiology Testing Market 2026-2030

出版日期: 2026年10月06日 | 出版商:

TechNavio | 英文 300 Pages | 訂單完成後即時交付

價格

簡介目錄

全球快速微生物檢測市場預計將從 2025 年到 2030 年成長至 28.594 億美元，預測期內複合年成長率為 10.1%。

本報告對全球快速微生物檢測市場進行了全面分析，包括市場規模和預測、趨勢、成長促進因素、挑戰以及供應商分析，涵蓋約 25 家供應商。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括自動化、微流體技術、人工智慧的技術融合、抗菌素抗藥性病原體的激增以及生物製藥生產中的品質保證標準。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

市場範圍
基準年	2025
年末	2030
調查期	2026-2030
成長勢頭	加速度
2026 年同比比較	9.7%
複合年成長率	10.1%
增量	28.594億美元

本研究指出，快速無菌檢測和即時環境監測的擴展將是未來幾年全球快速微生物檢測市場成長的關鍵促進因素。此外，高通量自動化、整合數位微生物檢測以及即時檢測和分散式分子檢測的加速發展預計也將產生巨大的市場需求。

區域分類
區域比較
北美洲
- 美國
- 加拿大
- 墨西哥
亞洲
- 中國
- 日本
- 印度
- 韓國
- 印尼
- 泰國
歐洲
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 荷蘭
世界其他地區（RoW）
- 巴西
- 沙烏地阿拉伯
- UAE
- 土耳其
- 阿根廷
- 哥倫比亞
- 南非
- 以色列
市場機會：按地區分類

第13章促進因素、挑戰與機遇

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機遇

第14章競爭格局

概述
競爭格局
中斷狀況
產業風險

第15章競爭分析

公司簡介
公司排名指標
企業市場定位
Abbott Laboratories
Agilent Technologies Inc.
Becton Dickinson and Co.
Bio Rad Laboratories Inc.
BioMerieux SA
Bruker Corp.
Charles River Laboratories
DiaSorin SpA
Eurofins Scientific SE
Hologic Inc.
Neogen Corp.
QIAGEN NV
Sartorius AG
Sigma Aldrich Chemicals Ltd.
Thermo Fisher Scientific Inc.

第16章附錄

簡介目錄

Product Code: IRTNTR74724

The global rapid microbiology testing market is forecasted to grow by USD 2859.4 mn during 2025-2030, accelerating at a CAGR of 10.1% during the forecast period. The report on the global rapid microbiology testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological integration of automation, microfluidics, and ai, surging incidence of antimicrobial-resistant pathogens, quality assurance standards in biopharmaceutical manufacturing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	9.7%
CAGR	10.1%
Incremental Value	$2859.4 mn

Technavio's global rapid microbiology testing market is segmented as below:

By Method

Growth-based
Nucleic-acid based
Viability-based
Others

By End-User

Hospitals and diagnostic laboratories
Pharmaceutical and biotechnology companies
Others

By Product Type

Reagents and kits
Instruments
Consumables

Geography

North America
- US
- Canada
- Mexico
Asia
Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
Rest of World (ROW)
Rest of World (ROW)

This study identifies the expansion of rapid sterility and real-time environmental monitoring as one of the prime reasons driving the global rapid microbiology testing market growth during the next few years. Also, high-throughput automation and integrated digital microbiology and acceleration of point-of-care and decentralized molecular detection will lead to sizable demand in the market.

The report on the global rapid microbiology testing market covers the following areas:

Global rapid microbiology testing market sizing
Global rapid microbiology testing market forecast
Global rapid microbiology testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global rapid microbiology testing market vendors that include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Bruker Corp., Charles River Laboratories, COPAN Diagnostics Inc., DiaSorin SpA, Eurofins Scientific SE, Hardy Diagnostics, Hologic Inc., LuminUltra Technologies Ltd, Neogen Corp., QIAGEN N.V., Sartorius AG, Sigma Aldrich Chemicals Ltd., Thermo Fisher Scientific Inc., Veolia Water Technologies. Also, the global rapid microbiology testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Method
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Rapid Microbiology Testing Market 2020 - 2024
- Historic Market Size - Data Table on Global Rapid Microbiology Testing Market 2020 - 2024 ($ million)
5.2 Method segment analysis 2020 - 2024
- Historic Market Size - Method Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI in Global Rapid Microbiology Testing Market
6.2 Impact of Geopolitical Conflicts on Global Rapid Microbiology Testing Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Method

8.1 Market segments
8.2 Comparison by Method
8.3 Growth-based - Market size and forecast 2025-2030
8.4 Nucleic-acid based - Market size and forecast 2025-2030
8.5 Viability-based - Market size and forecast 2025-2030
8.6 Others - Market size and forecast 2025-2030
8.7 Market opportunity by Method
- Market opportunity by Method ($ million)

9 Market Segmentation by End-user

9.1 Market segments
9.2 Comparison by End-user
9.3 Hospitals and diagnostic laboratories - Market size and forecast 2025-2030
9.4 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
9.5 Others - Market size and forecast 2025-2030
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)

10 Market Segmentation by Product Type

10.1 Market segments
10.2 Comparison by Product Type
10.3 Reagents and kits - Market size and forecast 2025-2030
10.4 Instruments - Market size and forecast 2025-2030
10.5 Consumables - Market size and forecast 2025-2030
10.6 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
12.4 Asia - Market size and forecast 2025-2030
- 12.4.1 China - Market size and forecast 2025-2030
- 12.4.2 Japan - Market size and forecast 2025-2030
- 12.4.3 India - Market size and forecast 2025-2030
- 12.4.4 South Korea - Market size and forecast 2025-2030
- 12.4.5 Indonesia - Market size and forecast 2025-2030
- 12.4.6 Thailand - Market size and forecast 2025-2030
12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 France - Market size and forecast 2025-2030
- 12.5.3 UK - Market size and forecast 2025-2030
- 12.5.4 Italy - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 The Netherlands - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Technological integration of automation, microfluidics, and AI
- Surging incidence of antimicrobial-resistant pathogens
- Quality assurance standards in biopharmaceutical manufacturing
13.2 Market challenges
- High capital acquisition costs and budgetary constraints
- Rigorous regulatory frameworks and stringent validation
- Operational frictions in legacy workflow integration
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Expansion of rapid sterility and real-time environmental monitoring
- High-throughput automation and integrated digital microbiology
- Acceleration of point-of-care and decentralized molecular detection

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
15.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
15.8 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
15.9 Bruker Corp.
- Bruker Corp. - Overview
- Bruker Corp. - Business segments
- Bruker Corp. - Key offerings
- Bruker Corp. - Segment focus
- SWOT
15.10 Charles River Laboratories
- Charles River Laboratories - Overview
- Charles River Laboratories - Business segments
- Charles River Laboratories - Key offerings
- Charles River Laboratories - Segment focus
- SWOT
15.11 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key news
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
15.12 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
15.13 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Product / Service
- Hologic Inc. - Key offerings
- SWOT
15.14 Neogen Corp.
- Neogen Corp. - Overview
- Neogen Corp. - Business segments
- Neogen Corp. - Key offerings
- Neogen Corp. - Segment focus
- SWOT
15.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
15.16 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- SWOT
15.17 Sigma Aldrich Chemicals Ltd.
- Sigma Aldrich Chemicals Ltd. - Overview
- Sigma Aldrich Chemicals Ltd. - Product / Service
- Sigma Aldrich Chemicals Ltd. - Key offerings
- SWOT
15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations